New Combination Respiratory Therapy for COPD Approved by FDA
A new double-combination therapy that promotes lung expansion and airway clearance has been approved by the U.S. Food and Drug Administration (FDA) for the ... Read more
Updates
-
-
Certain Cancer Therapies May Hold Promise in Treating COPD, Preclinical Study Suggests
Cancer therapies blocking specific protein receptors called ErbB reduced inflammation in animal models of inflammatory diseases — including those affecting the lung — by ... Read more -
New Assisted Breathing Device May Soon Be Available for Patients with Trouble Breathing
A newly developed assisted breathing device, based on the principles of older mechanical respirators but with more convenience and power, may soon be available ... Read more -
COPD Triple-combination Therapy Approved in China, AstraZeneca Announces
AstraZeneca’s triple-combination therapy for people with chronic obstructive pulmonary disease (COPD) has been approved in China as a maintenance treatment. The therapy comprises three compounds: ... Read more -
E-cigs Raise Risk of Chronic Lung Disease, Especially in Those Who Also Smoke, Study Finds
Using e-cigarettes significantly increases the risk of developing chronic lung diseases like asthma, bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD), a study found. ... Read more
-
Propeller’s Digital Health Tool Eases Provider Burden, Boosts COPD Patient Use, Study Finds
The use of Propeller Health’s digital health program, which integrates real-time data from chronic ... -
RejuvenAir System Granted CE Mark Approval in Europe to Treat COPD With Chronic Bronchitis
CSA Medical‘s RejuvenAir System has been granted CE Mark approval in Europe for treating people ... -
Zephyr Valve Favored as Standard of Care for Eligible COPD Patients in 2020 GOLD Report
The Global Initiative for Chronic Obstructive Disease (GOLD) recommends the use of endobronchial valves ... -
For COPD Awareness Month, Be Alert to Dangers of Indoor Air Pollutants, Company Advises
November is National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, and to recognize it ... -
Expanded Diagnostic Criteria Needed for COPD, Study Suggests
The criteria used to diagnose chronic obstructive pulmonary disease (COPD) should be expanded beyond ... -
Non-invasive Test to Diagnose Genetic Form of COPD Now Available in U.S.
AlphaID, a cheek swab test that can help identify patients with chronic obstructive pulmonary ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients
News
The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University ... Read more